Skip to main content

Exhibition and Partnership Opportunities

Please contact the congress organisation for further information on becoming an exhibitor and/or partner of the ESMINT Congress 2024:

ESMINT Congress 2023
c/o Congrex Switzerland Ltd.
Reinacherstrasse 131
4053 Basel / Switzerland

+41 61 686 77 96
+41 61 686 77 88
industry.esmint@congrex.com

Opportunity for Start-up companies

The Start-Up Alley offers start-ups a unique opportunity to showcase their presence at the ESMINT Congress and leverage the cutting-edge science and unmatched networking opportunities it provides.

Exhibition at the ESMINT Congress.

The 16th ESMINT Congress 2024 – the 16th Congress of the European Society of Minimally Invasive Neurological Therapy – is compliant with the MedTech Europe Code of Ethical Business Practice.

Kindly refer to the MedTech Europe listing.

Ethical MedTech Trusted Partner

Educational Grants

Educational grants are a wonderful opportunity to show your company’s support for the congress by promoting the attendance of physicians from both Europe and overseas.

The new MedTech Europe Ethical charter came into force from January 1, 2018 and in effect, direct sponsorship of Health Care Professionals (HCPs) by MedTech member companies is prohibited. As a result, these companies will have to channel their support through trusted partners such as Health Care Organisations (HCOs: i.e. hospitals, clinics, medical institutions), the ESMINT Society or the PCO (Professional Congress Organiser). Moreover, Congrex Switzerland, the PCO of the ESMINT Congress in Marseille, is a MedTech Europe Trusted Partner and is committed to comply with MedTech Europe’s ethical standards.

The ESMINT Society, in adhesion to the MedTech Europe Code of Ethical Business Practice, is seeking industry sponsorship to financially support Health Care Professionals in the field of interventional neuroradiology along with vascular neurology and neurosurgery to attend our 15th Congress of the European Society of Minimally Invasive Neurological Therapy.